Singapore, July 3 -- Insilico Biotechnology AG launches new data connectivity solution for coping with increased demand for predictive solutions in biologics manufacturing and process development.

An increasing amount of data from manufacturing and development in the biopharma industry is made available due to the advancement of data analysis and data collection tools. While capitalizing on the value of the data across projects offers a huge potential for reducing time and costs in manufacturing and development, data is often associated with systematic errors. These errors pose a high risk of false predictions, thus wrong decisions are made.

This is where Insilico's solution comes into play by combining both biochemical network models a...